Literature DB >> 28273552

Surgeon performed continuous intraoperative ultrasound guidance decreases re-excisions and mastectomy rates in breast cancer.

Guldeniz Karadeniz Cakmak1, Ali U Emre2, Oge Tascilar3, Burak Bahadir4, Selcuk Ozkan2.   

Abstract

BACKGROUND: Intraoperative ultrasound guided (IUG) breast conserving surgery (BCS) is being increasingly embraced by breast surgeons worldwide. We aimed to compare the efficacy of IUG-BCS for palpable and nonpalpable breast cancer with respect to margin status, re-excision rate, tissue sacrifice and cost-time analysis.
METHODS: Intraoperative localization protocol includes intraoperative ultrasound prior to excision to localize the lesion and guide the initial resection. The excised specimen was then examined visually and by palpation and the specimen and cavity was examined with ultrasound. Frozen sections were obtained routinely from a portion of all six faces of the resected specimen, and shaved cavity margins were sent for permanent histology.
RESULTS: Of the 208 patients, 57.2% had nonpalpable tumors. The sensitivity of ultrasound localization was 100%. Negative margins were achieved in 92.43% of nonpalpable and 91.01% of palpable lesions at initial procedure. The involved margins were correctly identified by the surgeon via specimen sonography in 95.4% of cases. Final positive margin rate was 2.4%. Calculated resection ratio and time analysis revealed nothing significant.
CONCLUSION: IUG-BCS is an invaluable and effective modality for obtaining clear surgical margins with optimum resection volumes and reducing re-operations. Furthermore, by means of this algorithm, in case of shaving cavity margins of the tumor bed for permanent analysis, frozen section evaluation might be omitted.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Breast conserving surgery; Intraoperative ultrasound

Mesh:

Year:  2017        PMID: 28273552     DOI: 10.1016/j.breast.2017.02.014

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  6 in total

Review 1.  Innovative Standards in Oncoplastic Breast Conserving Surgery: From Radical Mastectomy to Extreme Oncoplasty.

Authors:  Guldeniz Karadeniz Cakmak
Journal:  Breast Care (Basel)       Date:  2021-09-16       Impact factor: 2.860

2.  Impact of deformation on a supine-positioned image-guided breast surgery approach.

Authors:  Winona L Richey; Jon S Heiselman; Ma Luo; Ingrid M Meszoely; Michael I Miga
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-08-12       Impact factor: 3.421

3.  Intraoperative ultrasound-guided lumpectomy versus wire-guided excision for nonpalpable breast cancer.

Authors:  Xin Hu; Si Li; Yi Jiang; Wei Wei; Yinan Ji; Qiuyun Li; Zongbin Jiang
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

4.  Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective.

Authors:  Jeffery M Chakedis; Annie Tang; Gillian E Kuehner; Brooke Vuong; Liisa L Lyon; Lucinda A Romero; Benjamin M Raber; Melinda M Mortenson; Veronica C Shim; Nicole M Datrice-Hill; Jennifer R McEvoy; Vignesh A Arasu; Dorota J Wisner; Sharon B Chang
Journal:  Ann Surg Oncol       Date:  2021-08-26       Impact factor: 5.344

5.  Comparison of outcomes of surgeon-performed intraoperative ultrasonography-guided wire localization and preoperative wire localization in nonpalpable breast cancer patients undergoing breast-conserving surgery: A retrospective cohort study.

Authors:  Young Duck Shin; Young Jin Choi; Dae Hoon Kim; Sung Su Park; Hanlim Choi; Dong Ju Kim; Sungmin Park; Hyo Yung Yun; Young Jin Song
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 6.  Intraoperative ultrasound in breast cancer surgery-from localization of non-palpable tumors to objectively measurable excision.

Authors:  Natasa Colakovic; Darko Zdravkovic; Zlatko Skuric; Davor Mrda; Jasna Gacic; Nebojsa Ivanovic
Journal:  World J Surg Oncol       Date:  2018-09-11       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.